Innocan Pharma Corp (INNPF) Stock Price & News

All values in USD	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	7.01M	6.82M	4.99M	6.46M
Cost of goods sold	811.00K	631.00K	558.00K	575.00K
Cost of revenue	811.00K	631.00K	558.00K	575.00K
Research and development expenses	176.00K	415.00K	161.00K	184.00K
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	5.62M	6.99M	5.19M	6.49M
Operating expense	5.80M	7.41M	5.35M	6.68M
Total operating expenses	6.61M	8.04M	5.91M	7.25M
Operating income	396.00K	-1.22M	-922.00K	-786.00K
Other non operating income	-327.00K	-200.00K	1.93M	7.00K
EBT including unusual items	-109.00K	-1.43M	1.59M	-822.00K
EBT excluding unusual items	-17.00K	-1.30M	1.00M	-786.00K
Income tax expense	206.00K	220.00K	-262.00K	64.00K
Effective tax rate	-188.99%	-15.36%	-16.45%	-7.79%
Other operating expenses	-	-	-	-
Net income	-590.00K	-1.95M	2.00M	-972.00K
Net profit margin	-8.42%	-28.54%	40.00%	-15.03%
Earnings per share	-	-	-	-
Interest and investment income	-	7.00K	-	-
Interest expense	-4.00K	-	-3.00K	-7.00K
Net interest expenses	-4.00K	7.00K	-3.00K	-7.00K
Depreciation and amortization charges	-	-	-	-
EBITDA	405.00K	-1.21M	-910.00K	-778.00K
Gain or loss from assets sale	-	-	-	-

AI content may include mistakes. Learn more

Finance